Derby, United Kingdom

Sabaratnam Arulkumaran


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sabaratnam Arulkumaran: Innovator in Fetal Scalp Blood Sampling

Introduction

Sabaratnam Arulkumaran is a notable inventor based in Derby, GB. He has made significant contributions to the field of medical technology, particularly in the area of fetal health monitoring. His innovative approach has led to the development of a unique apparatus designed for fetal scalp blood sampling.

Latest Patents

Arulkumaran holds a patent for an "Apparatus and method for fetal scalp blood sampling." This invention provides a method and apparatus for collecting blood from a fetal scalp. The apparatus features an elongated housing that contains a longitudinally spring-loaded, sharp-pointed, beveled blade at the distal end. This blade can be advanced against the fetal scalp, allowing for precise blood collection. The design includes a groove on the exterior side surface of the housing, which is sized to receive a capillary tube. This tube is resiliently retained on the housing, ensuring that its distal end is positioned near a recessed region for effective blood pooling. The apparatus may also incorporate a light source to enhance visibility during the procedure.

Career Highlights

Sabaratnam Arulkumaran has been associated with Clinical Innovation Associates, Inc., where he has applied his expertise in medical device innovation. His work has focused on improving fetal monitoring techniques, which are crucial for ensuring the health and safety of both mothers and their unborn children.

Collaborations

Arulkumaran has collaborated with Wm Dean Wallace, contributing to advancements in medical technology and fetal health monitoring.

Conclusion

Sabaratnam Arulkumaran's innovative work in fetal scalp blood sampling exemplifies the impact of medical inventions on healthcare. His contributions continue to enhance the safety and effectiveness of fetal monitoring practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…